COVID-19 and opioid use disorder: Expanding treatment access in rural settings.
Journal
Nursing
ISSN: 1538-8689
Titre abrégé: Nursing
Pays: United States
ID NLM: 7600137
Informations de publication
Date de publication:
01 Sep 2021
01 Sep 2021
Historique:
entrez:
11
10
2021
pubmed:
12
10
2021
medline:
13
10
2021
Statut:
ppublish
Résumé
Substance use treatment inequities among rural populations are well documented and the COVID-19 pandemic has exacerbated these inequalities, forcing healthcare providers to be creative in the delivery of treatment. Systematic reviews on the use of telehealth to treat patients with substance use disorder indicate that it is a promising alternative to in-person services. This article examines the evidence supporting the use of telehealth in treating patients with opioid use disorder and explores other promising options that can help overcome pandemic-related barriers to treatment.
Identifiants
pubmed: 34633996
doi: 10.1097/01.NURSE.0000798204.89531.95
pii: 00152193-202109000-00012
doi:
Types de publication
Journal Article
Langues
eng
Pagination
44-47Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
James CV, Moonesinghe R, Wilson-Frederick SM, Hall JE, Penman-Aguilar A, Bouye K. Racial/ethnic health disparities among rural adults'United States, 2012-2015. Morb Mortal Wkly Rep (MMWR) . 2017;66(23):1–9.
James CV, Moonesinghe R, Wilson-Frederick SM, Hall JE, Penman-Aguilar A, Bouye K. Racial/ethnic health disparities among rural adults--United States, 2012-2015: MMWR surveillance summaries/November 17, 2017/66(23);1-9. J Health Care Poor Underserved . 2018;29(1):19–34.
Marcin JP, Shaikh U, Steinhorn RH. Addressing health disparities in rural communities using telehealth. Pediatr Res . 2016;79(1–2):169–176.
Lin LA, Casteel D, Shigekawa E, Weyrich MS, Roby DH, McMenamin SB. Telemedicine-delivered treatment interventions for substance use disorders: a systematic review. J Subst Abuse Treat . 2019;101:38–49.
Young LB. Telemedicine interventions for substance-use disorder: a literature review. J Telemed Telecare . 2012;18(1):47–53.
Weintraub E, Greenblatt AD, Chang J, Himelhoch S, Welsh C. Expanding access to buprenorphine treatment in rural areas with the use of telemedicine. Am J Addict . 2018;27(8):612–617.
Timko C, Schultz NR, Cucciare MA, Vittorio L, Garrison-Diehn C. Retention in medication-assisted treatment for opiate dependence: a systematic review. J Addict Dis . 2016;35(1):22–35.
Acevedo A, Panas L, Garnick D, et al. Disparities in the treatment of substance use disorders: does where you live matter. J Behav Health Serv Res . 2018;45(4):533–549.
Pinedo M. A current re-examination of racial/ethnic disparities in the use of substance abuse treatment: do disparities persist. Drug Alcohol Depend . 2019;202:162–167.
Ahmed F, Ahmed N, Pissarides C, Stiglitz J. Why inequality could spread COVID-19. Lancet Public Health . 2020;5(5):e240.
Kantamneni N. The impact of the COVID-19 pandemic on marginalized populations in the United States: a research agenda. J Vocat Behav . 2020;119:103439.
Hallgren KA, Ries RK, Atkins DC, Bumgardner K, Roy-Byrne P. Prediction of suicide ideation and attempt among substance-using patients in primary care. J Am Board Fam Med . 2017;30(2):150–160.
Slat S, Thomas J, Lagisetty P. Coronavirus disease 2019 and opioid use—a pandemic within an epidemic. JAMA Health Forum . 2020;1(5):e200628.
Hedegaard H, Miniño AM, Warner M. Drug overdose deaths in the United States, 1999-2017. NCHS Data Brief . 2018;(329):1–8.
Choi B. Opioid use disorder, job strain, and high physical job demands in US workers. Int Arch Occup Environ Health . 2020;93(5):577–588.
Substance Abuse and Mental Health Services Administration. Results from the 2019 National Survey on Drug Use and Health: Detailed Tables . Rockville, MD: Center for Behavioral Health Statistics and Quality; 2020.
Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health . Rockville, MD: Center for Behavioral Health Statistics and Quality; 2019.
US Department of Health and Human Services. Opioid abuse in the US and HHS actions to address opioid related drug overdoses and deaths. Office of the Assistant Secretary for Planning and Evaluation; 2015. https://aspe.hhs.gov/opioid-abuse-us-and-hhs-actions-address-opioid-drug-related-overdoses-and-deaths .
Browne T, Priester MA, Clone S, Iachini A, DeHart D, Hock R. Barriers and facilitators to substance use treatment in the rural south: a qualitative study. J Rural Health . 2016;32(1):92–101.
Rigg KK, Monnat SM, Chavez MN. Opioid-related mortality in rural America: geographic heterogeneity and intervention strategies. Int J Drug Policy . 2018;57:119–129.
Rosenblatt RA, Andrilla CHA, Catlin M, Larson EH. Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Ann Fam Med . 2015;13(1):23–26.
Hirchak KA, Murphy SM. Assessing differences in the availability of opioid addiction therapy options: rural versus urban and American Indian reservation versus nonreservation. J Rural Health . 2017;33(1):102–109.
Andrilla CHA, Moore TE, Patterson DG, Larson EH. Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: a 5-year update. J Rural Health . 2019;35(1):108–112.
Polinski JM, Barker T, Gagliano N, Sussman A, Brennan TA, Shrank WH. Patients' satisfaction with and preference for telehealth visits. J Gen Intern Med . 2016;31(3):269–275.
Nelson R. Telemedicine and telehealth: the potential to improve rural access to care. Am J Nurs . 2017;117(6):17–18.
Drug Enforcement Administration. How to prescribe controlled substances to patients during the COVID-19 public health emergency. 2020. www.deadiversion.usdoj.gov/GDP/(DEA-DC-023)(DEA075)Decision_Tree_(Final)_33120_2007.pdf .
Alexander GC, Stoller KB, Haffajee RL, Saloner B. An epidemic in the midst of a pandemic: opioid use disorder and COVID-19. Ann Intern Med . 2020;173(1):57–58.
Yang YT, Weintraub E, Haffajee RL. Telemedicine's role in addressing the opioid epidemic. Mayo Clin Proc . 2018;93(9):1177–1180.
Jenkins WD, Bolinski R, Bresett J, et al. COVID-19 during the opioid epidemic--exacerbation of stigma and vulnerabilities. J Rural Health . 2021;37(1):172–174.
Anderson M. About a quarter of rural Americans say access to high-speed internet is a major problem. Pew Research Center. 2018. www.pewresearch.org/fact-tank/2018/09/10/about-a-quarter-of-rural-americans-say-access-to-high-speed-internet-is-a-major-problem .
Substance Abuse and Mental Health Services Administration. Rural behavioral health: telehealth challenges and opportunities. SAMHSA In Brief . 2016;9(2):1–13.
Sun Y, Bao Y, Kosten T, Strang J, Shi J, Lu L. Challenges to opioid use disorders during COVID-19. Am J Addict . 2020;29(3):174–175.
Green TC, Bratberg J, Finnell DS. Opioid use disorder and the COVID-19 pandemic: a call to sustain regulatory easements and further expand access to treatment. Subst Abus . 2020;41(2):147–149.
American Society of Addiction Medicine. Caring for patients during the COVID-19 pandemic: ASAM COVID-19 task force recommendations. 2020. www.asam.org/docs/default-source/covid-19/drug-testing-guidance_042820.pdf?sfvrsn=ff854c2_2 .
University of New Mexico. Project ECHO - Extension for Community Healthcare Outcomes. https://hsc.unm.edu/echo .
Kennedy-Hendricks A, Barry CL, Gollust SE, Ensminger ME, Chisolm MS, McGinty EE. Social stigma toward persons with prescription opioid use disorder: associations with public support for punitive and public health-oriented policies. Psychiatr Serv . 2017;68(5):462–469.
Khoja S, Scott R, Husyin N, et al. Impact of simple conventional and telehealth solutions on improving mental health in Afghanistan. J Telemed Telecare . 2016;22(8):495–498.
Volkow ND. Collision of the COVID-19 and addiction epidemics. Ann Intern Med . 2020;173(1):61–62.